LncRNA PTCSC3 affects drug resistance of anaplastic thyroid cancer through STAT3/INO80 pathway

References

• Carling T, Udelsman R. Thyroid cancer. Annu Rev Med. 2014;65:125–37. doi:10.1146/annurev-med-061512-105739. PMID:24274180.
   PubMed Web of Science ®Google Scholar
• Maniakas A, Forest VI, Jozaghi Y, Saliba J, Hier MP, Mlynarek A, Tamilia M, Payne RJ. Tumor classification in well-differentiated thyroid carcinoma and sentinel lymph node biopsy outcomes: a direct correlation. Thyroid. 2014;24(4):671–4. doi:10.1089/thy.2013.0160. PMID:24199963.
   PubMed Web of Science ®Google Scholar
• Haddad RI, Lydiatt WM, Ball DW, Busaidy NL, Byrd D, Callender G, Dickson P, Duh QY, Ehya H. Anaplastic Thyroid Carcinoma, Version 2.2015. J Natl Compr Canc Netw. 2015;13(9):1140–50. doi:10.6004/jnccn.2015.0139. PMID:26358798.
   PubMed Web of Science ®Google Scholar
• Zheng X, Cui D, Xu S, Brabant G, Derwahl M. Doxorubicin fails to eradicate cancer stem cells derived from anaplastic thyroid carcinoma cells: characterization of resistant cells. Int J Oncol. 2010;37(2):307–15. PMID:20596658.
   PubMed Web of Science ®Google Scholar
• Decaussin-Petrucci M, Deladoëy J, Hafdi-Nejjari Z, Sassolas G, Borson-Chazot F, Abu-Khudir R, Fusco A, Descotes F, Cournoyer S, Sartelet H. Expression of CD133 in differentiated thyroid cancer of young patients. J Clin Pathol. 2015;68(6):434–40. doi:10.1136/jclinpath-2014-202625. PMID:25770162.
   PubMed Web of Science ®Google Scholar
• Pawlus MR, Wang L, Hu CJ. STAT3 and HIF1alpha cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells. Oncogene. 2014;33(13):1670–9. doi:10.1038/onc.2013.115. PMID:23604114.
   PubMed Web of Science ®Google Scholar
• Yu H, Lee H, Herrmann A, Buettner R, Jove R. Revisiting STAT3 signalling in cancer: new and unexpected biological functions. Nat Rev Cancer. 2014;14(11):736–46. doi:10.1038/nrc3818. PMID:25342631.
   PubMed Web of Science ®Google Scholar
• Tseng LM, Huang PI, Chen YR, Chen YC, Chou YC, Chen YW, Chang YL, Hsu HS, Lan YT, Chen KH. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells. J Pharmacol Exp Ther. 2012;341(2):410–23. doi:10.1124/jpet.111.188730. PMID:22328572.
   PubMed Web of Science ®Google Scholar
• Lafon A, Taranum S, Pietrocola F, Dingli F, Loew D, Brahma S, Bartholomew B, Papamichos-Chronakis M. INO80 Chromatin Remodeler Facilitates Release of RNA Polymerase II from Chromatin for Ubiquitin-Mediated Proteasomal Degradation. Mol Cell. 2015;60(5):784–96. doi:10.1016/j.molcel.2015.10.028. PMID:26656161.
   PubMed Web of Science ®Google Scholar
• Wang L, Du Y, Ward JM, Shimbo T, Lackford B, Zheng X, Miao YL, Zhou B, Han L. INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development. Cell Stem Cell. 2014;14(5):575–91. doi:10.1016/j.stem.2014.02.013. PMID:24792115.
   PubMed Web of Science ®Google Scholar
• Sheng W, Chen Y, Gong Y, Dong T, Zhang B, Gao W. miR-148a inhibits self-renewal of thyroid cancer stem cells via repressing INO80 expression. Oncol Rep. 2016;36(6):3387–96. doi:10.3892/or.2016.5203. PMID:27779717.
   PubMed Web of Science ®Google Scholar
• Jendrzejewski J, He H, Radomska HS, Li W, Tomsic J, Liyanarachchi S, Davuluri RV, Nagy R, de la Chapelle A. The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type. Proc Natl Acad Sci U S A. 2012;109(22):8646–51. doi:10.1073/pnas.1205654109. PMID:22586128.
   PubMed Web of Science ®Google Scholar
• Jendrzejewski J, Thomas A, Liyanarachchi S, Eiterman A, Tomsic J, He H, Radomska HS, Li W, Nagy R, Sworczak K. PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression. J Clin Endocrinol Metab. 2015;100(10):E1370–7. doi:10.1210/jc.2015-2247. PMID:26274343.
   PubMed Web of Science ®Google Scholar
• Xia S, Ji R, Zhan W. Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3 (PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway. Bmc Neurology. 2017;17(1):30. doi:10.1186/s12883-017-0813-6. PMID:28187755.
   PubMedGoogle Scholar
• Fragoso MA, Patel AK, Nakamura RE, Yi H, Surapaneni K, Hackam AS. The Wnt/beta-catenin pathway cross-talks with STAT3 signaling to regulate survival of retinal pigment epithelium cells. PLoS One. 2012;7(10):e46892. doi:10.1371/journal.pone.0046892. PMID:23056515.
   PubMed Web of Science ®Google Scholar
• Yang Y, Lu Y, Wu QY, Hu HY, Chen YH, Liu WL. Evidence of ATP assay as an appropriate alternative of MTT assay for cytotoxicity of secondary effluents from WWTPs. Ecotoxicol Environ Saf. 2015;122:490–6. doi:10.1016/j.ecoenv.2015.09.006. PMID:26410194.
   PubMed Web of Science ®Google Scholar
• Rodriguez-Ubreva J, Ballestar E. Chromatin immunoprecipitation. Methods Mol Biol. 2014;1094:309–18. doi:10.1007/978-1-62703-706-8_24. PMID:24162998.
   PubMedGoogle Scholar
• Bisof V, Rakusic Z, Despot M. Treatment of patients with anaplastic thyroid cancer during the last 20 y: whether any progress has been made? Eur Arch Otorhinolaryngol. 2015;272(7):1553–67. doi:10.1007/s00405-014-3108-1. PMID:24890977.
   PubMed Web of Science ®Google Scholar
• Giuffrida R, Adamo L, Iannolo G, Vicari L, Giuffrida D, Eramo A, Gulisano M, Memeo L, Conticello C. Resistance of papillary thyroid cancer stem cells to chemotherapy. Oncol Lett. 2016;12(1):687–91. doi:10.3892/ol.2016.4666. PMID:27347201.
   PubMed Web of Science ®Google Scholar
• Wang X, Lu X, Geng Z, Yang G, Shi Y. LncRNA PTCSC3/miR-574-5p governs cell proliferation and migration of papillary thyroid carcinoma via Wnt/β-catenin signaling. J of Cellular Bio. 2017;118(12):4745–52. doi:10.1002/jcb.26142. PMID:28513866.
   Google Scholar
• Li G, Zhao L, Li W, Fan K, Qian W, Hou S, Wang H, Dai J, Wei H, Guo Y. Feedback activation of STAT3 mediates trastuzumab resistance via upregulation of MUC1 and MUC4 expression. Oncotarget. 2014;5(18):8317–29. doi:10.18632/oncotarget.2135. PMID:25327561.
   PubMedGoogle Scholar
• Spitzner M, Roesler B, Bielfeld C, Emons G, Gaedcke J, Wolff HA, Rave-Fränk M, Kramer F, Beissbarth T, Kitz J. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo. Int J Cancer. 2014;134(4):997–1007. doi:10.1002/ijc.28429. PMID:23934972.
   PubMed Web of Science ®Google Scholar
• Kim TH, Lee SY, Rho JH, Jeong NY, Soung YH, Jo WS, Kang DY, Kim SH, Yoo YH. Mutant p53 (G199V) gains antiapoptotic function through signal transducer and activator of transcription 3 in anaplastic thyroid cancer cells. Mol Cancer Res. 2009;7(10):1645–54. doi:10.1158/1541-7786.MCR-09-0117. PMID:19825993.
   PubMed Web of Science ®Google Scholar
• Conaway RC, Conaway JW. The INO80 chromatin remodeling complex in transcription, replication and repair. Trends Biochem Sci. 2009;34(2):71–7. doi:10.1016/j.tibs.2008.10.010. PMID:19062292.
   PubMed Web of Science ®Google Scholar
• Mei D, Lv B, Chen B, Xiao S, Jiang J, Xie Y, Jiang L. All-trans retinoic acid suppresses malignant characteristics of CD133-positive thyroid cancer stem cells and induces apoptosis. PLoS One. 2017;12(8):e0182835. doi:10.1371/journal.pone.0182835. PMID:28817605.
   PubMed Web of Science ®Google Scholar
• Xu X, et al. Aldehyde dehydrogenases and cancer stem cells. Cancer Lett. 2015;369(1):50–7. doi:10.1016/j.canlet.2015.08.018. PMID:26319899.
   PubMed Web of Science ®Google Scholar